Get started
Author

Andreas Theuer

Observed name: A Theuer
OpenAlex ID: A5020042694
PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
2000 · J M Wood, G Bold, et al. · PubMed · 844
Antagonism of Sphingosine-1-Phosphate Receptors by FTY720 Inhibits Angiogenesis and Tumor Vascularization
2006 · Kenneth LaMontagne, Amanda Littlewood-Evans, et al. · Cancer Research · 302
A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis
2015 · Guido Bold, Christian Schnell, et al. · Journal of Medicinal Chemistry · 49
Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
2008 · Patrizia Sini, Ivana Samarzija, et al. · Cancer Research · 37
Data from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
2023 · Patrizia Sini, Ivana Samarzija, et al.
Supplementary Methods and Materials, Figure Legends 1-4 from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
2023 · Patrizia Sini, Ivana Samarzija, et al.
Supplementary Figure 2 from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
2023 · Patrizia Sini, Ivana Samarzija, et al.
PDF
Supplementary Figure 3 from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
2023 · Patrizia Sini, Ivana Samarzija, et al.
PDF
Supplementary Figure 4 from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
2023 · Patrizia Sini, Ivana Samarzija, et al.
PDF
Supplementary Figure 1 from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
2023 · Patrizia Sini, Ivana Samarzija, et al.
Supplementary Figure 4 from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
2023 · Patrizia Sini, Ivana Samarzija, et al.
Supplementary Figure 2 from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
2023 · Patrizia Sini, Ivana Samarzija, et al.
Supplementary Methods and Materials, Figure Legends 1-4 from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
2023 · Patrizia Sini, Ivana Samarzija, et al.
PDF
Supplementary Figure 1 from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
2023 · Patrizia Sini, Ivana Samarzija, et al.
PDF
Supplementary Figure 3 from Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics
2023 · Patrizia Sini, Ivana Samarzija, et al.
Abstract 5371: A pooled apoptome shRNA screen to identify pathways that enhance NVP-BEZ235-induced apoptosis
2011 · Elisabeth Buchdunger, Andreas Theuer, et al. · Cancer Research
Works count: 16
Citation count: 1,232
H-index: 4
I10-index: 4
Year
Topic
Type